Details for Patent: 6,123,916
✉ Email this page to a colleague
Summary for Patent: 6,123,916
| Title: | Therapeutic use of somatostatin peptides |
| Abstract: | The invention relates to a new pharmaceutical use of somatostatin peptides comprising on the terminal amino group a polyamino polycarboxylic group, in free form or in a pharmaceutically acceptable salt form, particularly in the manufacture of a medicament for treating disorders with an aetiology comprising or associated with excess of GH-secretion. |
| Inventor(s): | Krenning; Eric Paul (Rotterdam, NL), Lamberts; Steven Willem Jan (Rotterdam, NL) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 08/259,090 |
|
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 6,123,916
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,123,916
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 9004017 | Feb 22, 1990 |
International Family Members for US Patent 6,123,916
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Belgium | 1004645 | ⤷ Sign Up | |||
| Switzerland | 683318 | ⤷ Sign Up | |||
| Germany | 4104308 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
